Abstract
(2S,1'S,2'R)-2-(Carboxycyclopropyl)glycine (L-CCG III) was a substrate of Na+-dependent glutamate transporters (GluT) in Xenopus laevis oocytes (IC50 ∼ 13 and ∼2 μM for, respectively, EAAT 1 and EAAT 2) and caused an apparent inhibition of [3H]L-glutamate uptake in “mini-slices“ of guinea pig cerebral cortex (IC50 ∼ 12 μM). In slices (350 μM) of guinea pig cerebral cortex, 5 μM L-CCG III increased both the flux of label through pyruvate carboxylase and the fractional enrichment of glutamate, GABA, glutamine and lactate, but had no effect on total metabolite pool sizes. At 50 μM L-CCG III decreased incorporation of 13C from [3-13C]-pyruvate into glutamate C4, glutamine C4, lactate C3 and alanine C3. The total metabolite pool sizes were also decreased with no change in the fractional enrichment. Furthermore, L-CCG III was accumulated in the tissue, probably via GluT. At lower concentration, L-CCG III would compete with L-glutamate for GluT and the changes probably reflect a compensation for the “missing” L-glutamate. At 50 μM, intracellular L-CCG III could reach > 10 mM and metabolism might be affected directly.
Similar content being viewed by others
REFERENCES
Logan, W. J. and Snyder, S. H. 1971. Unique high affinity system for glycine, glutamic and aspartic acids in central nervous tissue. Nature 234:297–299.
Balcar, V. J. and Johnston, G. A. R. 1972. The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J. Neurochem. 19:2657–2666.
Bennett, M. R. and Balcar, V. J. 1999. Forty years of amino acid transmission in the brain. Neurochem. Int. 35:269–280.
Balcar, V. J., Takamoto, A., and Yoneda, Y. 2001. Neurochemistry of L-glutamate transport in the CNS: Thirty years of progress. Coll. Czech. Chem. Commun. 66:1315–1340.
Rothstein, J. D., Martin, L. J., and Kuncl, R. W. 1992. Decreased brain and spinal cord glutamate transport in amyotrophic lateral sclerosis. New Eng. J. Med. 326:1364–1468.
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., and Kuncl, R. W. 1995. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:3–84.
Scott, H. L., Tannenberg, A. E. C., and Dodd, P. R. 1995. Variant forms of neuronal glutamate transporter sites in Alzheimer disease cerebral cortex. J. Neurochem. 64:2193–2202.
Rao, V. L. R., Rao, A. M., Dogan, A., Bowen, K. K., Hatcher, J., Rothstein, J. D., and Dempsey, R. J. 2000. Glial glutamate transporter GLT down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global ischaemia. Neurochem. Int. 36:531–637.
Ferkany, J. and Coyle, J. T. 1986. Heterogeneity of sodiumdependent excitatory amino acid uptake mechanism in rat brain. J. Neurosci. Res. 16:491–503.
Balcar, V. J., Schousboe, A., Spoerri, P. E., and Wolff, J. R. 1987. Differences between substrate specificities of L-glutamate uptake by neurons and glia, studied in cell lines and primary cultures. Neurochem. Int. 10:213–218.
Robinson, M. B. and Dowd, L. A. 1997. Heterogeneity and functional subtypes of Na1–dependent glutamate transporters in the mammalian CNS. Adv. Pharmacol. 37:69–115.
Gegelashvili, G. and Schousboe, A. Cellular distribution and kinetic properties of high affinity glutamate transporters. 1998. Brain Res. Bull. 45:233–238.
Seal, R. P. and Amara, S. G. 1999. Excitatory amino acid transporters: a family in flux. Annual Rev. Pharmacol. Toxicol. 39:431–456.
Isaacson, J. S. and Nicoll, R. A. 1993. The uptake inhibitor L-t-PDC enhances the responses to glutamate but fails to Effect of a Glutamate Transport Inhibitor on Brain Metabolism In Vitro 33 alter the kinetcs of excitatory synaptic currents in the hippocampus. J. Neurophysiol. 70:2187–2191.
Tong, G. and Jahr, C. E. 1994. Block of glutamate transporters potentiates postsynaptic excitation. Neuron 13:1195–1203.
Diamond, J. S. and Jahr, C. E. 2000. J. Synaptically released glutamate does not overwhelm transporters on hippocampal astrocytes during high-frequency stimulation. Neurophysiol. 83, 2835–2843.
Choi, D. W. 1992. Excitotoxic cell death. J. Neurobiol. 23:1261–1276.
Rothstein, J. D., Jin, L., Dykes-Hoberg, M., and Kuncl, R. W. 1993. Chronic glutamate uptake inhibition produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 90:6591–6595.
Blitzblau, R., Gupta, S., Djali, S., Robinson, M. B., and Rosenberg, D. A. 1996. The glutamate transport inhibitor L-t-2,4–PDC indirectly evokes NMDA-receptor mediated neurotoxicity in rat cortical cultures. Eur. J. Neurosci. 8:1840–1852.
Massieu, L., Morales-Villagran, A., and Tapia, R. 1995. Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64:2262–2272.
Ong, W. Y., Motin, L. G., Hansen, M. A., Diaz, J. S., Bennett, M. R., and Balcar, V. J. 1997. A P2 purinoceptor blocker suramin antagonizes NMDA receptors and protects against excitatory behaviour caused by NMDA receptor agonist (RS)-(tetrazol-5–yl)-glycine in rats. J. Neurosci. Res. 49:627–637.
Bruno, V., Copani, A., Battaglia, G., Raffaele, R., Shinozaki, H., and Nicoletti, F. 1994. Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur. J. Pharmacol. 256:109–112.
Bond, A., O'Neill, M. J., Hicks, C. A., Mon, J. A., and Lodge, D. 1998. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport 9:1191–1193.
Behrens, M. M., Strasser, U., Heidiger, V., Lobner, D., Yu, S. P., McDonald, J. W., Won, M., and Choi, D. W. 1999. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity. Neuropharmacol. 38:1621–1630.
Pliss, L., FitzGibbon, T., Balcar, V. J., and Štastný, F. 2000. Neurotoxicity of NAAG in vivo is sensitive to NMDA antagonists and mGluR II ligands. NeuroReport 11:3651–3654.
Cartmell, J. and Schoepp, D. D. 2000. Regulation of neurotransmitter release by etabotropic glutamate receptors. J. Neurochem. 75:889–907.
Johnston, G. A. R., Lodge, D., Bornstein, J. C., and Curtis, D. R. 1980. Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereoisomers of threo-3–hydroxyaspartate. J. Neurochem. 34:241–243.
Lievens, J. C., Dutertre, M., Forni, C., Salin, P., and Kerkorian-LeGoff, L. 1997. Continuous administration of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4–dicarboxylate produces striatal lesion. Mol. Brain Res. 50:181–189.
Garcia, O. and Massieu, L. 2001. Strategies for neuroprotection against L-trans-pyrrolidine-2,4–dicarboxylate-induced neuronal damage during energy impairment in vitro. J. Neurosci. Res. 64:418–428.
Rae, C., Lawrence, M. L., Diaz, L. S., Provis, T., Bubb, W. A., and Balcar, V. J. 2000. Strategies for studies of neurotoxic mechanisms involving deficient transport of L-glutamate: Antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pig brain slices. Brain Res. Bull. 53:373–381.
Fowden, L., Smith, A., Millington, D. S., and Sheppard, R. C. 1969. Cyclopropane amino acids from Aesculus and Blighia. Phytochem. 6:437–443.
Pellicciari, R., Natalini, B., Marinozzi, M., Selvi, L., Chiorri, C., Monahan, J. B., Lanthorn, T. H., and Snyder, J. P. 1988. 3,4–Cyclopropyl glutamates as conformationally restricted agonists of the NMDA receptor. Pages 67–70, in Cavalheiro, E. A., Lehman, L., and Turski, L. (eds.), Frontiers in Excitatory Amino Acid Research, Alan Liss, Inc., New York.
Nakamura, Y., Kataoka, Y., Ishida, M., and Shinozaki, H. 1993. (2S,3S,4R)-2–(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate. Neuropharmacol. 32:833–837.
Robinson, M. B., Sinor, J. D., Dowd, L. A., and Kerwin, J. F., Jr. 1993. Subtypes of sodium-dependent high affinity L-3Hglutamate transport activity: pharmacologic specificity and regulation by potassium and sodium. J. Neurochem. 50:167–179.
Dunlop, J., Lou, Z., and McIlvain, H. B. 1999. Properties of excitatory amino acid transport in the human U373 astrocytoma cell line. Brain Res. 839:235–242.
Lieb, I., Chebib, M., Cooper, B., Diaz, L. S., and Balcar, V. J. 2000. Quantitative autoradiography of Na+-dependent [3H]Laspartate binding to L-glutamate transporters in rat brain: structure-activity studies using L-trans-pyrrolidine-2,4–dicarboxylate (L-t-PDC) and 2–(carboxycyclopropyl)-glycine (CCG). Neurochem. Int. 36:319–327.
Balcar, V. J., Li, Y., and Killinger, S. 1995. Effects of L-transpyrrolidine-2,4–dicarboxylate and L-threo-3–hydroxyaspartate on the binding of [3H]L-aspartate, [3H]a-amino-3–hydroxy-5–methyl-4–isoxazolepropionate (AMPA), [3H]DL-(E)-2–amino-4–propyl-5–phosphono-3–pentenoate (CGP 39653), [3H]6–cyano-7–nitroquinoxaline-2,3–dione (CNQX) and [3H]kainate studied by autoradiography in rat forebrain. Neurochem. Int. 26:155–164.
Killinger, S., Blum, G. L., Bohart, A., Bested, A. Dias, L. S., Cooper, B., Allan, R. D., and Balcar, V. J. 1996. Autoradiographic studies indicate regional variations in the characteristics of L-glutamate transporters in rat brain. Neurosci. Lett. 216:101–104.
Shimamoto, K., Lebrun, B., Yasuda-Katamani, Y., Sakaitani, M., Shigeri, Y., Yumoto, N., and Nakajima, T. 1998. DL-threob-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol. Pharmacol. 53:195–201.
Shimamoto, K., Shigeri, Y., Yasuda-Kamatani, Y., Lebrun, B., Yumoto, N., and Nakajima, T. 2000. Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers. Bioorg. Med. Chem. Lett. 53:2407–2410.
Robinson, M. B. 1999. The family of sodium-dependent glutamate transporters: A focus on GLT-1/EAAT2 subtype. Neurochem. Int. 26:155–164.
Vandenberg, R. J. 1999. Molecular pharmacology and physiology of glutamate transporters in the central nervous system. Clin. Exp. Pharmacol. Physiol. 25:393–400.
Vandenberg, R. J., Arriza, J. L., Amara, S. G., and Kavanaugh, M. P. 1995. Constitutive ion fluxes and substrate binding domains of human glutamate transporters. J. biol. Chem. 270:17668–17671.
Balcar, V. J. and Li, Y. 1992. Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci. 51:1467–1478.
Badar-Goffer, R. S., Bachelard, H. S., and Morris, P. G. 1990. Cerebral metabolism of acetate and glucose studied by 13C-n.m.r. spectroscopy. Biochem. J. 266:133–139.
Kupce, E. and Freeman, R. 1995. Adiabatic pulses for wideband inversion and broadband decoupling. J. Magn. Res. A 115:273–276.
Skinner, T. E. and Bendall, M. R. 1997. A phase-cycling algorithm for reducing sidebands in adiabatic decoupling. J. Magn. Res. 124:474–478.
Wilker, W., Leibfritz, D., Kerssenbaum, R., and Bermel, W. 1993. Gradient selection in inverse heteronuclear correlation spectroscopy. Magn. Res. Chem. 31:287–292.
Sonnewald, U., Hertz, L., and Schousboe, A. 1998. Mitochondrial heterogeneity in the brain at the cellular level. J. Cereb. Blood Flow Metab. 18:231–237.
Shimamoto, K., Ishida, M., Shinozaki, H., and Ohfune, Y. 1991. Synthesis of four diastereomeric L-2–(carboxycyclopropyl) glycines. Conformationally constrained L-glutamate analogs. J. Org. Chem. 56:4167–4176.
Rife, J., Ortuno, R. M., and Lajoi, G. A. 1999. Stereoselective synthesis of L-2–(carboxycyclopropyl)glycines via stereocontrolled 1,3–dipolar cycloadditions of diazomethane on 1,3–dipolar cyclo additions of diazomethane on Z-and E-3,4–L-didehydroglutamates OBO esters. J. Org. Chem. 64:8958–8961.
Balcar, V. J., Twitchin, B., and Johnston, G. A. R. 1977. Stereospecificity of the inhibition of L-glutamate and L-aspartate high affinity uptake in rat brain slices by threo-3–hydroxyaspartate. J. Neurochem. 28:1145–1146.
Rothstein, J. D., Martin, L. J., Levey, A. I., and Dykes-Hoberg, M., 1994. Localization of neuronal and glial glutamate transporters. Neuron 13:713–725.
Lehre, K. P., Levey, L. M., Ottersen, O. P., Storm-Mathisen, J., and Danbolt, N. C. 1995. Differential expression of two glial glutamate transporters in the rat brain. J. Neurosci. 15:1835–1853.
Danbolt, N. C. 2001. Glutamate uptake. Prog. Neurobiol. 65:1–105.
Balcar, V. J. and Johnston, G. A. R. 1975. High affinity uptake of L-glutamine in rat brain slices. J. Neurochem. 24:875–879.
Mennerick, S., Dhond, R. P. Benz, A., Xu, W., Rothstein, J. D., Danbolt, N. C., Isenberg, K. E., and Zorumski, C. F. 1998. Neuronal expression of the glutamate transporter GLT-1 in hipocampal microcultures. J. Neurosci. 18:4490–4499.
Meaney, J., Balcar, V. J., Rothstein, J. D., and Jeffrey, P. L. 1998. Glutamate transport in cultures from developing avian cerebellum. J. Neurosci. Res. 54:595–603.
Northington, F. J., Traystman, R. J., Krehler, R. C., and Martin, L. J. 1999. GLT-1, glial glutamate transporter, is transiently expressed in neurons and develops astrocyte specificity only after midgestation in the ovine fetal brain. J. Neurobiol. 39:515–526.
Plachez, C., Danbolt, N. C., and Recasens, M. 2000. Transient expression of the glial glutamate transporters GLAST and GLT-1 in hippocampal neurons in primary culture. J. Neurosci. Res. 59:587–593.
Schmitt, A., Asan, E., Püschel, B., Jons, Th., and Kugler, P. 1996. Expression of the glutamate transporter GLT-1 in neural cells of the rat central nervous system. Neurosci. 71:989–1004.
Schmitt, A., Asan, E., Püschel, B., and Kugler, P. 1997. Cellular and regional distribution of the glutamate transporter GLAST in the CNS of rats: non-radioactive in situ hybridization and comparative immunocytochemistry. J. Neurosci. 17:1–10.
Johanson, S. O., Li, Y., and Balcar, V. J. 1995. Glutamate decarboxylase solubilized from the rat cerebral cortex by two different concentrations of Triton X-100: Effects of glutamate analogues and analysis by SDS-PAGE/Western blotting using GAD6 and K2 antibodies. Neurochem. Int. 26:179–185.
Pellerin, L. and Magistretti, P. J. 1994. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Nat. Acad. Sci. USA 91:10625–10629.
Debernardi, R., Magistretti, P. J., and Pellerin, L. 1999. Trans-inhibition of glutamate transport prevents excitatory amino acid-induced glycolysis in astrocytes. Brain Res. 850:39–46.
Jabaudon, D., Shimamoto, K., Yasumi-Kamatani, Y., Scanziani, M., Gähwiler, B. H., and Gerber, U. 1999. Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin. Proc. Nat. Acad. Sci. USA 96:8733–8738.
Jabaudon, D., Scanziani, M., Gähwiler, B. H., and Gerber, U. 2000. Acute decrease in net glutamate uptake during energy deprivation. Proc. Nat. Acad. Sci. USA 97:5610–5615.
Hertz, L., Dringen, R., Schousboe, A., and Robinson, S. R. 1999. Astrocytes: Glutamate producers for neurons. J. Neurosci. Res. 57:417–42.
Dunlop, J. 2001. Substrate exchange properties of the high affinity glutamate transporter EAAT2. J. Neurosci. Res. 66:482–486.
Takamoto, A., Quiggin, L. B., Lieb, I., Shave, E., Balcar V. J., and Yoneda, Y. 2001. Differences between D-and L-aspartate binding to the Na1–dependent binding sites on glutamate transporters in frozen sections of rat brain. Life Sci., in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moussa, C.EH., Mitrovic, A.D., Vandenberg, R.J. et al. Effects of L-Glutamate Transport Inhibition by a Conformationally Restricted Glutamate Analogue (2S,1'S,2'R)-2-(Carboxycyclopropyl)Glycine (L-CCG III) on Metabolism in Brain Tissue In Vitro Analysed by NMR Spectroscopy. Neurochem Res 27, 27–35 (2002). https://doi.org/10.1023/A:1014842303583
Issue Date:
DOI: https://doi.org/10.1023/A:1014842303583